CRH Ventures Launches “Sustainable Building Materials” Accelerator to Scale Innovative Startups Shaping the Future of the Built World
CRH Ventures, the venture capital unit of CRH, the leading building materials solutions business, today announced the launch of its latest accelerator, Sustainable Building Materials. Applications to the program are open until December 16.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241021822864/en/
Eduardo Gomez Mendoza, Head of CRH Ventures (Photo: Business Wire)
CRH is leading the transition to smarter, more sustainable construction and the Sustainable Building Materials accelerator will target promising Seed-, Series A- and Series B-stage companies in the construction technology (“contech”) and climate tech space with market-ready products. The program aims to identify innovative materials and applications to lower emissions, reduce waste and improve energy use - leveraging CRH’s extensive network and expertise to drive forward innovative and sustainable solutions for the built environment.
The accelerator will focus on exploring three key areas to enable more sustainable construction:
- Sustainable binder solutions — companies enhancing the carbon performance and / or the circularity of traditional cement or concrete materials
- New materials and applications —companies developingnovel materials or new applications of existing materials to create non-traditional solutions for cement or concrete applications
- CO2 mineralized materials —companies utilizing CO2 in binders, aggregates, waste feedstocks or concrete to develop building materials or products that also offer carbon storage
This accelerator will identify startups poised to capitalize on the significant market opportunity decarbonization represents and support them as they develop and scale their operations. CRH Ventures will arrange one or more pilot programs for each shortlisted applicant, providing commercial users for products and facilitating technology refinement and engagement with selected partners in the construction space. Startups will also gain broader access to CRH’s network of 200+ operating companies, gaining insight from CRH experts and exploring synergies as they scale their technologies. Participants in the accelerator will also be eligible for potential investments from CRH Ventures at the conclusion of the pilot programs.
Eduardo Gomez, Head of CRH Ventures, said: “There’s an incredible opportunity to reduce construction-related emissions and enhance circularity through innovation. At CRH, we’re uniquely positioned to support the development of sustainable and innovative solutions and technologies to meet the changing needs of construction. In launching the Sustainable Building Materials accelerator, we plan to identify the most impactful innovations, and drive their commercial development through our network to support the construction industry to decarbonize and help CRH achieve its 2050 net-zero ambition.”
The accelerator will be accepting applicants via the CRH Ventures website through December 16. The selection process will continue throughout November and December, and will culminate in a live pitch day in early February 2025 for the most promising 10-12 startups.
Launched in 2022, CRH Ventures has established itself as a leader in construction innovation, with access to a $250-million venturing & innovation investment fund and a growing group of portfolio companies innovating across the construction value chain.
The Sustainable Building Materials program is CRH Ventures’ third accelerator. Earlier this year, it successfully launched the Roads of the Future accelerator to identify leading innovations with potential to impact the roads ecosystem and in 2023, it launched a Water Solutions accelerator focused on technologies that address a range of water management challenges.
About CRH Ventures
CRH Ventures is the venture capital unit of CRH, the leading provider of building materials solutions that build, connect and improve our world. With access to a $250M Venturing and Innovation Fund, CRH Ventures partners with and invests ambitiously and strategically in ConTech and ClimateTech start-ups across the entire construction value chain. For more information visit www.crhventures.com.
About CRH
CRH (NYSE: CRH, LSE: CRH) is the leading provider of building materials solutions that build, connect and improve our world. Employing approximately 78,500 people at approximately 3,390 operating locations in 28 countries, CRH has market leadership positions in both North America and Europe. As the essential partner for transportation and critical utility infrastructure projects, complex non-residential construction and outdoor living solutions, CRH’s unique offering of materials, products and value-added services helps to deliver a more resilient and sustainable built environment. The company is ranked among sector leaders by Environmental, Social and Governance (ESG) rating agencies. A Fortune 500 company, CRH’s shares are listed on the NYSE and the LSE. For more information visit www.crh.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241021822864/en/
Contacts
Media:
Jack Shaw
Antenna Group (for CRH Ventures)
CRH-Ventures@antennagroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz ® ) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 01:45:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) in adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal cancer (SCAC) who have not been previously treated with systemic chemotherapy, were published in The Lancet.1 “The publication of the POD1UM-303/InterAACT 2 trial in The Lancet is a testament to the strength of the data generated for retifanlimab in patients with inoperable locally recurrent or metastatic SCAC, a disease which until recently had seen limited innovation for decades,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “SCAC can be a devastating disease, and patients often have a poor prognosis. These data supported the U.S. Food and Drug Administration (FDA) approval of Zynyz® (retifanl
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 22:30:00 EEST | Press release
Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal, but a core driver of innovation. Key milestones include a near-complete transition to natural refrigerants
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 21:45:00 EEST | Press release
Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of European enterprises, providing a framework for high performance in even the most complex, secure environments. “With about 6 million developers across Europe, users deserve infrastructure that meets them where they are,” said Varun Mohan, CEO of Windsurf. “The demand for secure AI-powered development is undeniable and by launching this GPU cluster, we aim to b
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 20:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization journey, allowing developers to focus on building engaging games, not commerce infrastructure. This SDK connects three
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 18:00:00 EEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom